Highlights from the 25th National GEDO Day – Biomedicine Agency
Biomedicine Agency shared a post on LinkedIn:
“A look back at the Agency’s participation in the 25th National GEDO Day
The Biomedicine Agency is delighted to have been able to participate in this anniversary edition of the Study Group for Egg Donation (GEDO) around the common thread ‘Evidence and uncertaint'”.
During the workshop dedicated to regulatory aspects in oocyte donation and ovarian failure:
- Chloé Baron and Samuel Arrabal took a concrete look at the European SoHO regulation applied to multidisciplinary egg donation platforms.
- Dr. Claire de Vienne shared his vision on secondary egg donation in France, shedding light on the essential role of private centers in donation pathways.
Their interventions have fuelled debates, provoked reflections and strengthened our conviction: combining scientific rigour, ethics and solidarity is essential to advance biomedicine for the benefit of patients.
A big thank you to the GEDO and the organizers for their welcome, the quality of the exchanges and this strong moment of co-construction.
To find out more about egg donation.”
-
Sep 13, 2026, 15:11Sachintha Alwis: From Impaired Sperm Motility to Microrobotics
-
Sep 13, 2026, 15:08Laurence Orbuch: Before Endometriosis Surgery, Ask…
-
Sep 13, 2026, 15:05Ademola Ayodele: IUI, IVF or Egg Freezing – Which One Is Right for You?
-
Sep 13, 2026, 14:59Fiona Pathiraja-Møller: Tennis Players No Longer Have to Choose Between Career and Family
-
Sep 13, 2026, 14:571-Day Virtual Experience for People Impacted by PMOS – PCOS Awareness Association
-
Sep 13, 2026, 14:53Ozor Victor: Behind Every Embryo Is a Story of Science, Precision, and Hope
-
Sep 13, 2026, 14:50Diana Kayal: What They Don’t Tell You About IVF
-
Sep 13, 2026, 14:44Vikram Sinai Talaulikar: A Heartfelt Thank You to All Who Donated and Supported “Menopause and Cancer”
-
Sep 13, 2026, 14:41Nicole McPherson: Changing IVF Practices Is Hard – Integration Needs to Be Easy